(Q46664893)

24 December 2017

title

Lipid-lowering therapy is related to inflammatory markers and 3-year mortality in patients with critical limb ischemia (English)

1 reference

24 December 2017

5

Anders Gottsäter

1 reference

24 December 2017

Bengt Lindblad

4

object named as

Bengt Lindblad

1 reference

24 December 2017

author name string

Nazim Isma

1

1 reference

24 December 2017

Jamal Barani

2

1 reference

24 December 2017

Ingrid Mattiasson

3

1 reference

24 December 2017

publication date

2 April 2008

1 reference

24 December 2017

published in

Angiology

1 reference

24 December 2017

volume

59

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

542-548

1 reference

24 December 2017

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Current perspectives on statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

The evolving role of statins in the management of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Non-lipid-related effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

The lack of cardiovascular risk factor management in patients with critical limb ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Inflammatory mediators are associated with 1-year mortality in critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

The prevalence of peripheral arterial disease in a defined population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

C-reactive protein levels and outcomes after statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Effect of atorvastatin on the expression of CD40 ligand and P-selectin on platelets in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Serum lipids act as inverse acute phase reactants and are falsely low in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Effect of statin (HMG-Co-A-Reductase Inhibitor) use on 1-year mortality and hospitalization rates in older patients with cardiovascular disease living in nursing homes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Compliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707306144

21 January 2018

Identifiers

DOI

10.1177/0003319707306144

1 reference

24 December 2017

PubMed ID

18388063

1 reference

24 December 2017